These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 39271520

  • 1. The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial.
    Elbarbary NS, Ismail EA, El-Hamamsy MH, Ibrahim MZ, Elkholy AA.
    Diabetologia; 2024 Dec; 67(12):2637-2649. PubMed ID: 39271520
    [Abstract] [Full Text] [Related]

  • 2. Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.
    Asgharzadeh A, Patel M, Connock M, Damery S, Ghosh I, Jordan M, Freeman K, Brown A, Court R, Baldwin S, Ogunlayi F, Stinton C, Cummins E, Al-Khudairy L.
    Health Technol Assess; 2024 Dec; 28(80):1-190. PubMed ID: 39673446
    [Abstract] [Full Text] [Related]

  • 3. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial.
    Kim P, Sanchez AM, Penke TJR, Tuson HH, Kime JC, McKee RW, Slone WL, Conley NR, McMillan LJ, Prybol CJ, Garofolo PM.
    Lancet Infect Dis; 2024 Dec; 24(12):1319-1332. PubMed ID: 39134085
    [Abstract] [Full Text] [Related]

  • 4. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM, Thom H, Sheppard AL, Keeney E, O'Donnell R, Jackson J, Roadevin C, Dawson S, Lane D, Stubbs J, Everitt H, Watson JC, Hay AD, Gillett P, Robins G, Jones HE, Mallett S, Whiting PF.
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC, Chen CW, Yen HK, Lin YP, Lai CY, Wang JL, Groot OQ, Janssen SJ, Schwab JH, Hsu FM, Lin WH.
    Clin Orthop Relat Res; 2024 Dec 01; 482(12):2193-2208. PubMed ID: 39051924
    [Abstract] [Full Text] [Related]

  • 6. Tamoxifen for adults with hepatocellular carcinoma.
    Naing C, Ni H, Aung HH.
    Cochrane Database Syst Rev; 2024 Aug 12; 8(8):CD014869. PubMed ID: 39132750
    [Abstract] [Full Text] [Related]

  • 7. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT.
    Coulton S, Nizalova O, Pellatt-Higgins T, Stevens A, Hendrie N, Marchand C, Vass R, Deluca P, Drummond C, Ferguson J, Waller G, Newbury-Birch D.
    Public Health Res (Southampt); 2023 Mar 12; 11(3):1-77. PubMed ID: 37254608
    [Abstract] [Full Text] [Related]

  • 8. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A, Hiu S, Kunonga PT, Gajjar K, Craig D, Vale L, Winter-Roach BA, Elattar A, Naik R.
    Cochrane Database Syst Rev; 2022 Sep 26; 9(9):CD015048. PubMed ID: 36161421
    [Abstract] [Full Text] [Related]

  • 9. Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial.
    Chowdary P, Angchaisuksiri P, Apte S, Astermark J, Benson G, Chan AKC, Jiménez Yuste V, Matsushita T, Høgh Nielsen AR, Sathar J, Sutton C, Šaulytė Trakymienė S, Tran H, Villarreal Martinez L, Wheeler AP, Windyga J, Young G, Thaung Zaw JJ, Eichler H.
    Lancet Haematol; 2024 Dec 26; 11(12):e891-e904. PubMed ID: 39521008
    [Abstract] [Full Text] [Related]

  • 10. Experiences of adolescents and young adults with type 1 diabetes and chronically elevated glucose levels following the transition from multiple daily injections to advanced hybrid closed-loop: A qualitative study.
    Wong JY, Styles SE, Wiltshire EJ, de Bock MI, Boucsein A, Palmer OJ, Wheeler BJ.
    Diabet Med; 2025 Jan 26; 42(1):e15449. PubMed ID: 39377427
    [Abstract] [Full Text] [Related]

  • 11.
    Smith KC, Choi Y, Blackford AL, DeSanto J, Mayonado N, Rall S, White S, Bowie J, Hannum S, Johnston F, Joyner RL, Mischtschuk J, Peairs KS, Thorner E, Tran PT, Wolff AC, Snyder CF, Simplifying Survivorship Care Planning Stakeholder Advisory Board.
    ; 2022 05 26. PubMed ID: 39666842
    [Abstract] [Full Text] [Related]

  • 12. Interpersonal counselling for adolescent depression delivered by youth mental health workers without core professional training: the ICALM feasibility RCT.
    Wilson J, Cestaro V, Charami-Roupa E, Clarke T, Dunne A, Gee B, Jarrett S, Katangwe-Chigamba T, Laphan A, McIvor S, Meiser-Stedman R, Murdoch J, Rhodes T, Seeley C, Shepstone L, Turner D, Wilkinson P.
    Health Soc Care Deliv Res; 2024 Dec 26; 12(48):1-121. PubMed ID: 39673502
    [Abstract] [Full Text] [Related]

  • 13. An arterial spin labeling-based radiomics signature and machine learning for the prediction and detection of various stages of kidney damage due to diabetes.
    Ma F, Shao X, Zhang Y, Li J, Li Q, Sun H, Wang T, Liu H, Zhao F, Chen L, Chen J, Zhou S, Ji Q, Yu P.
    Front Endocrinol (Lausanne); 2024 Dec 26; 15():1333881. PubMed ID: 39624821
    [Abstract] [Full Text] [Related]

  • 14. Diabetes as a risk factor for tuberculosis disease.
    Franco JV, Bongaerts B, Metzendorf MI, Risso A, Guo Y, Peña Silva L, Boeckmann M, Schlesinger S, Damen JA, Richter B, Baddeley A, Bastard M, Carlqvist A, Garcia-Casal MN, Hemmingsen B, Mavhunga F, Manne-Goehler J, Viney K.
    Cochrane Database Syst Rev; 2024 Aug 23; 8(8):CD016013. PubMed ID: 39177079
    [Abstract] [Full Text] [Related]

  • 15. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J, Gaudet LA, Saba S, Vandermeer B, Ashiq AR, Wingert A, Hartling L.
    Syst Rev; 2024 Nov 26; 13(1):289. PubMed ID: 39593159
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial.
    Vermeire S, Schreiber S, Rubin DT, D'Haens G, Reinisch W, Watanabe M, Mehta R, Roblin X, Beales I, Gietka P, Hibi T, Hospodarskyy I, Ritter T, Genovese MC, Kwon P, Santermans E, Le Brun FO, Barron R, Masior T, Danese S.
    Lancet Gastroenterol Hepatol; 2024 Dec 02. PubMed ID: 39637881
    [Abstract] [Full Text] [Related]

  • 17. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT.
    Crawley E, Anderson E, Cochrane M, Shirkey BA, Parslow R, Hollingworth W, Mills N, Gaunt D, Treneman-Evans G, Rai M, Macleod J, Kessler D, Pitts K, Cooper S, Loades M, Annaw A, Stallard P, Knoop H, Van de Putte E, Nijhof S, Bleijenberg G, Metcalfe C.
    Health Technol Assess; 2024 Oct 02; 28(70):1-134. PubMed ID: 39485730
    [Abstract] [Full Text] [Related]

  • 18. Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis.
    Curry N, Davenport R, Thomas H, Fox E, Lucas J, Evans A, Massou E, Sharma R, Shanmugaranjan S, Rourke C, Newton A, Deary A, Dallas N, Fitzpatrick-Creamer C, Podbielski JM, Wade CE, Edwards A, Benger J, Morris S, Cotton BA, Piercy J, Green L, Brohi K, Stanworth S.
    Health Technol Assess; 2024 Nov 02; 28(76):1-69. PubMed ID: 39545850
    [Abstract] [Full Text] [Related]

  • 19. Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021.
    Gentzke AS, Wang TW, Cornelius M, Park-Lee E, Ren C, Sawdey MD, Cullen KA, Loretan C, Jamal A, Homa DM.
    MMWR Surveill Summ; 2022 Mar 11; 71(5):1-29. PubMed ID: 35271557
    [Abstract] [Full Text] [Related]

  • 20. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
    Cooper TE, Khalid R, Chan S, Craig JC, Hawley CM, Howell M, Johnson DW, Jaure A, Teixeira-Pinto A, Wong G.
    Cochrane Database Syst Rev; 2023 Oct 23; 10(10):CD013631. PubMed ID: 37870148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.